Oramed Pharma (ORMP)
$1.94
0.01 (0.52%)
ORMP Stock Quote Delayed 30 Minutes
Why Is Oramed (ORMP) Stock Down 75% Today?
Oramed (ORMP) stock is falling hard Thursday after announcing a Phase 3 clinical trial of its diabetes treatment missed its primary endpoint.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
63.08M
PE Ratio
4.31
EPS
0.45
Volume (Avg. Vol.)
1.58M
Day's Range
$1.89 - $1.96
52-Week Range
$1.81 - $13.73
Dividend & Yield
N/A (N/A)
